VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F950. A total of 5 filers reported holding VERTEX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $389,000 | -58.6% | 3,300 | -58.2% | 0.01% | -46.7% |
| Q4 2014 | $939,000 | +104.1% | 7,900 | +92.7% | 0.02% | +66.7% |
| Q3 2014 | $460,000 | -48.8% | 4,100 | -56.8% | 0.01% | -35.7% |
| Q2 2014 | $899,000 | +1.7% | 9,500 | -24.0% | 0.01% | +27.3% |
| Q1 2014 | $884,000 | -42.3% | 12,500 | -39.3% | 0.01% | -35.3% |
| Q4 2013 | $1,531,000 | -29.2% | 20,600 | -27.7% | 0.02% | -39.3% |
| Q3 2013 | $2,161,000 | – | 28,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 30,100 | $10,466,974 | 0.04% |
| SIMPLEX TRADING, LLC | 82,500 | $28,688 | 0.02% |
| Maven Securities LTD | 5,400 | $1,877,796 | 0.02% |
| Allianz Asset Management GmbH | 25,400 | $8,832,596 | 0.02% |
| IMC-Chicago, LLC | 41,300 | $14,361,662 | 0.01% |
| JANE STREET GROUP, LLC | 73,300 | $25,489,342 | 0.01% |
| JPMORGAN CHASE & CO | 49,300 | $17,143,582 | 0.00% |
| SG Americas Securities, LLC | 15,000 | $93 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |